Rebecca Daly

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Childhood Cancer

Papillary Thyroid

Top Venues

Cancer medicine

Journal of personalized medicine

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Eden G Robertson, Kate Hetherington, Rebecca Daly, Mark W Donoghoe, Nicholas Handelsman, David S Ziegler, Claire E Wakefield
The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer. Cancer medicine 13 (12) (2024)
Eden G Robertson, Kate Hetherington, Rebecca Daly, Mark W Donoghoe, Nicholas Handelsman, David S Ziegler, Claire E Wakefield
The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer. Cancer medicine 13 (12) (2024)
Rebecca Daly, Kate Hetherington, Bethany R Wadling, Chris Jacobs, Jonathan Karpelowsky, Claire E Wakefield
It provides families with other avenues for treatment when there are no other options Surgeons' perspectives of being part of a precision medicine trial for poor prognosis paediatric cancer patients: A short report. Cancer medicine 13 (9) (2024)
Rebecca Daly, Kate Hetherington, Bethany R Wadling, Chris Jacobs, Jonathan Karpelowsky, Claire E Wakefield
It provides families with other avenues for treatment when there are no other options Surgeons' perspectives of being part of a precision medicine trial for poor prognosis paediatric cancer patients: A short report. Cancer medicine 13 (9) (2024)
Carolyn G Mazariego, Rebecca Daly, Brittany C McGill, Lauren Kelada, Skye McKay, Kate Hetherington, David S Ziegler, Claire E Wakefield, Natalie Taylor
Barriers to access of precision guided therapies for children with high-risk cancer. Pediatric blood & cancer (2024)
Eden G Robertson, Kate Hetherington, Rebecca Daly, Mark W Donoghoe, Nicholas Handelsman, David S Ziegler, Claire E Wakefield
The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer. Cancer medicine 13 (12) (2024)
Rebecca Daly, Kate Hetherington, Bethany R Wadling, Chris Jacobs, Jonathan Karpelowsky, Claire E Wakefield
It provides families with other avenues for treatment when there are no other options Surgeons' perspectives of being part of a precision medicine trial for poor prognosis paediatric cancer patients: A short report. Cancer medicine 13 (9) (2024)
Rebecca Daly, Kate Hetherington, Emily Hazell, Bethany R Wadling, Vanessa Tyrrell, Katherine M Tucker, Glenn M Marshall, David S Ziegler, Loretta M S Lau, Toby N Trahair, Tracey A O'Brien, Kiri Collins, Andrew J Gifford, Michelle Haber, Mark Pinese, David Malkin, Mark J Cowley, Jonathan Karpelowsky, Donna Drew, Chris Jacobs, Claire E Wakefield
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial. Journal of personalized medicine 13 (7) (2023)
Kate Hetherington, Claire E Wakefield, Kavitha P K Kunalan, Mark W Donoghoe, Brittany C McGill, Joanna E Fardell, Rebecca Daly, Rebecca J Deyell, David S Ziegler
Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer. Cancers 14 (21) (2022)